These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
475 related articles for article (PubMed ID: 34445641)
1. Interactions of Bacteriophages with Animal and Human Organisms-Safety Issues in the Light of Phage Therapy. Podlacha M; Grabowski Ł; Kosznik-Kawśnicka K; Zdrojewska K; Stasiłojć M; Węgrzyn G; Węgrzyn A Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445641 [TBL] [Abstract][Full Text] [Related]
6. Bacteriophages: an overview of the control strategies against multiple bacterial infections in different fields. Jamal M; Bukhari SMAUS; Andleeb S; Ali M; Raza S; Nawaz MA; Hussain T; Rahman SU; Shah SSA J Basic Microbiol; 2019 Feb; 59(2):123-133. PubMed ID: 30485461 [TBL] [Abstract][Full Text] [Related]
7. Applications of bacteriophages versus phage enzymes to combat and cure bacterial infections: an ambitious and also a realistic application? Maciejewska B; Olszak T; Drulis-Kawa Z Appl Microbiol Biotechnol; 2018 Mar; 102(6):2563-2581. PubMed ID: 29442169 [TBL] [Abstract][Full Text] [Related]
8. The dawn of phage therapy. Rehman S; Ali Z; Khan M; Bostan N; Naseem S Rev Med Virol; 2019 Jul; 29(4):e2041. PubMed ID: 31050070 [TBL] [Abstract][Full Text] [Related]
9. Biotechnological applications of bacteriophages: State of the art. Harada LK; Silva EC; Campos WF; Del Fiol FS; Vila M; Dąbrowska K; Krylov VN; Balcão VM Microbiol Res; 2018; 212-213():38-58. PubMed ID: 29853167 [TBL] [Abstract][Full Text] [Related]
10. Phage therapy: What factors shape phage pharmacokinetics and bioavailability? Systematic and critical review. Dąbrowska K Med Res Rev; 2019 Sep; 39(5):2000-2025. PubMed ID: 30887551 [TBL] [Abstract][Full Text] [Related]
11. Characterization of four virulent Klebsiella pneumoniae bacteriophages, and evaluation of their potential use in complex phage preparation. Zurabov F; Zhilenkov E Virol J; 2021 Jan; 18(1):9. PubMed ID: 33407669 [TBL] [Abstract][Full Text] [Related]
13. Bacteriophage interactions with mammalian tissue: Therapeutic applications. Huh H; Wong S; St Jean J; Slavcev R Adv Drug Deliv Rev; 2019 May; 145():4-17. PubMed ID: 30659855 [TBL] [Abstract][Full Text] [Related]
14. Phage Therapy in the Resistance Era: Where Do We Stand and Where Are We Going? Luong T; Salabarria AC; Roach DR Clin Ther; 2020 Sep; 42(9):1659-1680. PubMed ID: 32883528 [TBL] [Abstract][Full Text] [Related]
15. The Diverse Impacts of Phage Morons on Bacterial Fitness and Virulence. Taylor VL; Fitzpatrick AD; Islam Z; Maxwell KL Adv Virus Res; 2019; 103():1-31. PubMed ID: 30635074 [TBL] [Abstract][Full Text] [Related]
16. Controlled phage therapy by photothermal ablation of specific bacterial species using gold nanorods targeted by chimeric phages. Peng H; Borg RE; Dow LP; Pruitt BL; Chen IA Proc Natl Acad Sci U S A; 2020 Jan; 117(4):1951-1961. PubMed ID: 31932441 [TBL] [Abstract][Full Text] [Related]
17. Bacteriophages and cancer. Budynek P; Dabrowska K; Skaradziński G; Górski A Arch Microbiol; 2010 May; 192(5):315-20. PubMed ID: 20232198 [TBL] [Abstract][Full Text] [Related]
18. Formulation, stabilisation and encapsulation of bacteriophage for phage therapy. Malik DJ; Sokolov IJ; Vinner GK; Mancuso F; Cinquerrui S; Vladisavljevic GT; Clokie MRJ; Garton NJ; Stapley AGF; Kirpichnikova A Adv Colloid Interface Sci; 2017 Nov; 249():100-133. PubMed ID: 28688779 [TBL] [Abstract][Full Text] [Related]